FL S1250

Creates section 385.2021 of Florida Statutes to establish legislative findings on the importance of diverse patient participation in cancer clinical trials and barriers created by uncovered costs.

Requires cancer clinical trial programs to inform potential participants before enrollment that reimbursement for travel and ancillary costs is available based on financial need and that family members or caregivers attending treatments are also eligible for reimbursement.

Authorizes corporations, individuals, foundations, health care providers, and other stakeholders to offer financial support through third-party nonprofit corporations and public charities to reimburse ancillary costs and travel expenses for cancer clinical trial participants.

Specifies that offers to reimburse travel and ancillary expenses are not considered inducements for trial participation when made without coercion or undue influence, and distinguishes such reimbursement from prohibited payment inducements.

Requires the Department of Health to review and approve reimbursement programs offered by nonprofit corporations and public charities, ensuring patient subjects are fairly recruited, adequately informed, and that expenses are appropriate; authorizes the department to adopt administrative rules.